Discovery of new tranylcypromine derivatives as highly potent LSD1 inhibitors

Discovery of new tranylcypromine derivatives as highly potent LSD1 inhibitors Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells Synthesis and evaluation of small molecule inhibitors of LSD1 for use against MYCN-expressing neuroblastoma Design, synthesis and biological evaluation of [1,2,4]triazolo[1,5-a]pyrimidines as potent lysine specific demethylase 1 (LSD1/KDM1A) inhibitors Selective 5-Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: A novel class of irreversible inhibitors of histone demethylase KDM1A Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy 4-Hydroxy-3-methylbenzofuran-2-carbohydrazones as novel LSD1 inhibitors